How Has Treatment Evolved for Newly Diagnosed Hodgkin Lymphoma?

In this episode of “Blood Cancer Talks,” the hosts are joined by Nancy Bartlett, MD, of the Washington University School of Medicine in St. Louis, to discuss how treatment for newly diagnosed Hodgkin lymphoma has evolved over time.

Dr. Bartlett and the hosts explore the history of first-line treatments for patients with Hodgkin lymphoma who are young and fit. They also discuss key developments in treatment from the last decade, highlighting the ECHELON-1, BREACH, SWOG S1826, FIL-ROUGE, and HD21 studies.  Additionally, they discuss the RATHL and S0816 trials, which evaluated imaging-adapted treatment of advanced Hodgkin lymphoma.

This podcast originally appeared on Blood Cancer Talks.